Related Experiment Video

Updated: May 7, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

12.8K

HSF1-mediated regulation of tumor cell apoptosis: a novel target for cancer therapeutics

Sanjay Kumar1, Munendra Singh Tomar, Arbind Acharya

  • 1Centre of Advance Study in Zoology, Faculty of Science, Banaras Hindu University, Varanasi-221 005, U.P., India.

Future Oncology (London, England)
|October 11, 2013
PubMed

Insights

Heat shock factor 1 (HSF1) activation, induced by protein kinase C (PKC), regulates programmed cell death (apoptosis). Inhibiting HSF1 shows promise for novel cancer therapeutics by inducing apoptosis in tumor cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Programmed cell death (apoptosis) is a fundamental biological process crucial for development and tissue homeostasis.
  • Protein kinase C (PKC) activation, triggered by cellular stress, initiates signaling cascades leading to heat shock factor 1 (HSF1) activation.
  • HSF1 activation results in the overexpression of heat shock proteins, which modulate the apoptotic pathway.

Purpose of the Study:

  • To elucidate the precise role of HSF1 in regulating apoptosis.
  • To explore the therapeutic potential of targeting HSF1 in cancer treatment.
  • To investigate the effects of pharmacological inhibitors on HSF1-mediated apoptosis.

Main Methods:

  • Review of existing literature on apoptosis, PKC signaling, and HSF1 activation.
  • Analysis of the interplay between heat shock proteins and apoptotic pathways.
  • Examination of studies on pharmacological inhibitors of PKC and their impact on HSF1.

Main Results:

  • Overexpression of heat shock proteins interferes with apoptosis; their inhibition promotes apoptosis.
  • HSF1 activation is a key downstream event in stress-induced PKC signaling.
  • Pharmacological PKC inhibitors can inhibit HSF1 activation, leading to apoptosis in tumor cells.

Conclusions:

  • HSF1 represents a potential novel therapeutic target for various tumors.
  • Targeting HSF1 offers a promising strategy for anti-cancer interventions.
  • Further research is needed to fully understand the therapeutic implications of pharmacological inhibitors in HSF1-regulated apoptosis.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.2K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K